A Single Arm, Prospective Clinical Study Using Novel Wearable Sensors to Assess the Improvement of Nocturnal Scratch Behavior and Sleep Quality in Children With Mild-to-moderate Atopic Dermatitis Treated With Topical Crisaborole
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Crisaborole (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 25 Oct 2019 Planned End Date changed from 1 Dec 2019 to 1 Nov 2021.
- 25 Oct 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Sep 2021.
- 25 Oct 2019 Status changed from not yet recruiting to recruiting.